Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5976
PUT
Axsome Therapeutics
AXSM
$11.2B
| $752K | ﹤0.01% |
29,200
-27,800
| -49% | -$557K |
|
|
ERF
5977
CALL
DELISTED
Enerplus Corporation
ERF
| $752K | ﹤0.01% |
99,900
+15,100
| +18% | +$124K |
|
5978
CALL
Ameren
AEE
$30.4B
| $751K | ﹤0.01% |
10,000
-21,200
| -68% | -$1.56M |
|
5979
PUT
Teucrium Corn Fund
CORN
$171M
| $750K | ﹤0.01% |
45,600
+19,200
| +73% | +$305K |
|
|
PVLA
5980
Palvella Therapeutics
PVLA
$2.25B
| $750K | ﹤0.01% |
1,995
+277
| +16% | +$82.6K |
|
|
SRRA
5981
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $750K | ﹤0.01% |
33,468
-1
| -0% | -$48 |
|
5982
Smith & Wesson
SWBI
$643M
| $749K | ﹤0.01% |
108,152
-68,279
| -39% | -$484K |
|
5983
Calumet Specialty Products
CLMT
$4.19B
| $747K | ﹤0.01% |
178,243
+55,941
| +46% | +$224K |
|
5984
iShares New York Muni Bond ETF
NYF
$1.41B
| $747K | ﹤0.01% |
+13,159
| New | +$741K |
|
5985
CALL
Entegris
ENTG
$24.7B
| $746K | ﹤0.01% |
+20,000
| New | +$758K |
|
|
PRA
5986
DELISTED
ProAssurance
PRA
| $746K | ﹤0.01% |
20,648
-172,608
| -89% | -$6.42M |
|
|
MINC
5987
DELISTED
AdvisorShares Newfleet Multi-Sector Income ETF
MINC
| $746K | ﹤0.01% |
15,411
+3,077
| +25% | +$148K |
|
5988
ALPS Clean Energy ETF
ACES
$125M
| $745K | ﹤0.01% |
25,143
-3,920
| -13% | -$111K |
|
5989
CALL
Merit Medical Systems
MMSI
$5.42B
| $745K | ﹤0.01% |
12,500
-10,400
| -45% | -$596K |
|
5990
CALL
ProShares Short Russell2000
RWM
$98.9M
| $745K | ﹤0.01% |
18,700
-3,300
| -15% | -$134K |
|
|
PRAH
5991
DELISTED
PRA Health Sciences, Inc.
PRAH
| $745K | ﹤0.01% |
7,514
-375,301
| -98% | -$35.8M |
|
|
WBID
5992
DELISTED
WBI BullBear Quality 2000 ETF
WBID
| $745K | ﹤0.01% |
37,336
+14,392
| +63% | +$290K |
|
5993
CALL
NovaGold Resources
NG
$3.48B
| $744K | ﹤0.01% |
125,900
+22,800
| +22% | +$97.3K |
|
5994
CALL
Rambus
RMBS
$10.9B
| $744K | ﹤0.01% |
61,800
+21,700
| +54% | +$249K |
|
5995
Shake Shack
SHAK
$3.02B
| $744K | ﹤0.01% |
10,305
+4,556
| +79% | +$281K |
|
5996
CALL
Advanced Energy
AEIS
$13.2B
| $743K | ﹤0.01% |
13,200
+3,200
| +32% | +$171K |
|
|
EEX
5997
DELISTED
Emerald Holding
EEX
| $743K | ﹤0.01% |
66,634
-60,899
| -48% | -$759K |
|
5998
CALL
MACOM Technology Solutions
MTSI
$24.2B
| $743K | ﹤0.01% |
49,100
-3,300
| -6% | -$49.7K |
|
5999
PUT
Oshkosh
OSK
$9.44B
| $743K | ﹤0.01% |
8,900
-2,500
| -22% | -$197K |
|
6000
WSFS Financial
WSFS
$4.17B
| $743K | ﹤0.01% |
17,983
-130,254
| -88% | -$5.4M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.